Modern medication regimens have transformed HIV from a deadly disease into a chronic disease, with some patients now ...

Every week, 4000 young women contract HIV. Discover hidden barriers to prevention and innovative solutions that can change ...

CNBC’s Angelica Peebles and Gilead chairman and CEO Daniel O’Day join 'Squawk Box' to discuss the company's new HIV ...

The government provides HIV medicines free of charge. Yet in one Indigenous territory, cases and deaths are increasing at an ...

The Supreme Court said Friday it will review the constitutionality of the Affordable Care Act’s no-cost coverage mandates for ...

Here are some of the findings from UNAIDS' new report on HIV and human rights, and what they could mean for the fight against ...

Discover the latest advancements in HIV prevention and how they offer hope for reducing infections, especially in the Black ...

The Food and Drug Administration has approved the OraQuick® HIV Self-Test to include individuals 14 years of age and older.

Among treatment-naive people with HIV, dolutegravir/lamivudine showed viral suppression comparable with those of other ...

Drought and heavy rainfall also increased the risk of HIV and sexually transmitted infections (STIs), particularly among ...

Abia State Agency for the Control of AIDS, ABSACA, has disclosed that 46,788 persons are currently undergoing treatment for ...

Gilead's chief executive calls lenacapavir a once in a decade medicine. The HIV treatment could push Gilead stock further up ...